Table 3.
Authors | Jung et al. (21) | Sallustio et al. (22) | Present report |
---|---|---|---|
Number of cases | 19 | 24 | 12 |
Age (years, mean/median) | 69 (median) | 69 (mean) | 64 (mean) |
Baseline NIHSS (mean/median) | 16 (median) | 14.2 (mean) | 17.2 (mean) |
Cancer stage IV (%) | 89% | 42% | 58% |
Prestroke mRS ≦ 2 (%) | N/A | 96% | 83% |
IV thrombolysis (%) | 17% | 50% | 33% |
P2R (min) | 30 | 53 | 70 |
TICI 2b or 3 (%) | 37% | 77% | 83% |
mRS 0–2 at 3 months (%) | 16% | 42% | 25% |
mRS 6 at 3 months (%) | 63% | 29% | 50% |
mRS 0–2 at 12 months (%) | N/A | N/A | 8% |
mRS 6 at 12 months (%) | N/A | N/A | 92% |
IV, intravenous; mRS, modified Rankin Scale; P2R, puncture to reperfusion; N/A, not applicable.